Cell-associated HIV RNA: a dynamic biomarker of viral persistence

被引：105

作者：

Pasternak, Alexander O. ^{[1
]}

Lukashov, Vladimir V. ^{[1
]}

Berkhout, Ben ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands

来源：

RETROVIROLOGY | 2013年 / 10卷

关键词：

Cell-associated HIV RNA; Virological biomarker; HIV-1; persistence; reservoir; Antiretroviral therapy; HIV cure; IMMUNODEFICIENCY-VIRUS TYPE-1; REAL-TIME PCR; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; COURSE RALTEGRAVIR INTENSIFICATION; HIGHLY SENSITIVE METHODS; IN-SITU HYBRIDIZATION; MESSENGER-RNA;

D O I：

10.1186/1742-4690-10-41

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In most HIV-infected individuals adherent to modern antiretroviral therapy (ART), plasma viremia stays undetectable by clinical assays and therefore, additional virological markers for monitoring and predicting therapy responses and for measuring the degree of HIV persistence in patients on ART should be identified. For the above purposes, quantitation of cell-associated HIV biomarkers could provide a useful alternative to measurements of viral RNA in plasma. This review concentrates on cell-associated (CA) HIV RNA with the emphasis on its use as a virological biomarker. We discuss the significance of CA HIV RNA as a prognostic marker of disease progression in untreated patients and as an indicator of residual virus replication and the size of the dynamic viral reservoir in ART-treated patients. Potential value

引用

页数：15

共 167 条

[21] Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia [J].

Dandri, Maura ;

Murray, John M. ;

Lutgehetmann, Marc ;

Volz, Tassilo ;

Lohse, Ansgar W. ;

Petersen, Joerg .

HEPATOLOGY, 2008, 48 (04) :1079-1086

[22] Towards an HIV cure: a global scientific strategy [J].

Deeks, Steven G. .

NATURE REVIEWS IMMUNOLOGY, 2012, 12 (08) :607-614

[23] HIV How to escape treatment [J].

Deeks, Steven G. .

NATURE, 2011, 477 (7362) :36-37

[24] HIV Infection, Inflammation, Immunosenescence, and Aging [J].

Deeks, Steven G. .

ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 :141-155

[25] Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay [J].

Désiré, N ;

Dehée, A ;

Schneider, V ;

Jacomet, C ;

Goujon, C ;

Girard, PM ;

Rozenbaum, W ;

Nicolas, JC .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1303-1310

[26] AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion [J].

deWolf, F ;

Spijkerman, I ;

Schellekens, PT ;

Langendam, M ;

Kuiken, C ;

Bakker, M ;

Roos, M ;

Coutinho, R ;

Miedema, F ;

Goudsmit, J .

AIDS, 1997, 11 (15) :1799-1806

[27] In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months [J].

Di Mascio, M ;

Dornadula, G ;

Zhang, H ;

Sullivan, J ;

Xu, Y ;

Kulkosky, J ;

Pomerantz, RJ ;

Perelson, AS .

JOURNAL OF VIROLOGY, 2003, 77 (03) :2271-2275

[28] Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].

Dornadula, G ;

Zhang, H ;

VanUitert, B ;

Stern, J ;

Livornese, L ;

Ingerman, MJ ;

Witek, J ;

Kedanis, RJ ;

Natkin, J ;

DeSimone, J ;

Pomerantz, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632

[29] Low-level viraemia on HAART: significance and management [J].

Doyle, Tomas ;

Geretti, Anna Maria .

CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (01) :17-25

[30] MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].

EMBRETSON, J ;

ZUPANCIC, M ;

RIBAS, JL ;

BURKE, A ;

RACZ, P ;

TENNERRACZ, K ;

HAASE, AT .

NATURE, 1993, 362 (6418) :359-362

← 1 2 3 4 5 6 7 8 9 10 →